{"cmr":"ca-cm-kg/TSX/GUD","since":null,"total":14,"cursor":0,"limit":50,"next_cursor":null,"events":[{"cmr":"ca-cm-kg/TSX/GUD","date":"2026-11-05","event_type":"financial_statement","title":"Knight Therapeutics Reports Third Quarter 2026 Results","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/11/05/3396184/0/en/knight-therapeutics-reports-third-quarter-2026-results.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"2x2zpfCfkkG6NHXoQlO0jr3vPXefo9pLnG2lQrxIPZYuyP1oWpOuB2tRVGjgvLVsq7Mn_T5zywMyJGtJgC1iAA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/GUD","date":"2026-10-29","event_type":"financial_statement","title":"Notice of Knight Therapeutics' Third Quarter 2026 Results","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/29/3391155/0/en/notice-of-knight-therapeutics-third-quarter-2026-results-conference-call.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"T6zDO3RfwLdyWyCAKNmM0CqUzHtZro53mrzapo1lfVEBsQn9NJAkh3Wi3RUxw8Al4pXEXKLP0umqtBEFrXcFDw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/GUD","date":"2026-10-06","event_type":"newswire_release","title":"Knight Therapeutics Announces Regulatory Approval of","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/06/3375375/0/en/knight-therapeutics-announces-regulatory-approval-of-niktimvo-in-brazil.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"h137H55o7Xmhu-DkcdBermkwz9WnWpH2yNtzxGtOaELYp4r5nLZbcqdfEs9EZu4ETA5BZbSAbRc6SFPHC0NQBA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/GUD","date":"2026-10-06","event_type":"newswire_release","title":"Knight Therapeutics Announces Launch of TAVALISSE® in","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/10/06/3375365/0/en/knight-therapeutics-announces-launch-of-tavalisse-in-brazil.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"qwwr9SW6gc53v4Bnzzqhrcva7e3-Xjud_NFsuiL0Re156ZwLSd_USNUCJ_r8dYySptHCGJoE3TsYGLByUK7VDA","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/GUD","date":"2026-09-29","event_type":"corporate_action","title":"Knight Therapeutics Enters into Exclusive Distribution","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/29/3370704/0/en/knight-therapeutics-enters-into-exclusive-distribution-agreement-with-kyowa-kirin-international-for-poteligeo-mogamulizumab.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"zbDQ8dNjnITDY2cOChPNe8CWv5TP4eFHabmnDzPHEiIT_WoEO4clzAT5BzAaA_Hm0GFlVVOZCY5v4bja-_L2Dg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/GUD","date":"2026-09-29","event_type":"newswire_release","title":"Kyowa Kirin and Knight Therapeutics Enter Into Exclusive ...","wire":"Business Wire","source":"Business Wire","url":"https://www.businesswire.com/news/home/20260929434860/en/Kyowa-Kirin-and-Knight-Therapeutics-Enter-Into-Exclusive-Distribution-Agreement-for-POTELIGEO-mogamulizumab-for-Cutaneous-T-Cell-Lymphoma-CTCL-Patients-Across-Latin-America","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"fdFKEJJw3J962O9r2EyNfis11eLq6w-o7fF074FwO81cGmwday-WT-1Oa8p28DNpCFx-5i2sR3d_eXB3qWYVBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/GUD","date":"2026-09-25","event_type":"newswire_release","title":"Knight Therapeutics Inc. places No. 345 on The Globe and","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/25/3369164/0/en/knight-therapeutics-inc-places-no-345-on-the-globe-and-mail-s-eighth-annual-ranking-of-canada-s-top-growing-companies.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"ZrsTRWndWGwSz4jDRZJRPbe8GAZBD-n_PTHf7FTBenqK6VEdP2gUahLfcz28uO3RJfbpiFOC3UzHqw00fwhZDQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/GUD","date":"2026-09-25","event_type":"newswire_release","title":"Knight Therapeutics Inc. ocupa el puesto nº 345 en la ...","wire":"PR Newswire","source":"PR Newswire","url":"https://www.prnewswire.com/mx/comunicados-de-prensa/knight-therapeutics-inc-ocupa-el-puesto-n-345-en-la-octava-edicion-de-la-clasificacion-anual-de-las-empresas-canadienses-de-mayor-crecimiento-de-the-globe-and-mail-302890296.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"g5U4VuA2VH5X6Jz3QBKvXNsbRmw_wKvKB7YPMKKHHgNcox1k4KefJWIY5_gOaRYvFLaDOrrfi01G4JJEeG3DBQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/GUD","date":"2026-09-15","event_type":"newswire_release","title":"Knight Therapeutics Announces Regulatory Submission of","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/09/15/3361951/0/en/knight-therapeutics-announces-regulatory-submission-of-gemtesa-in-canada.html","read_by":"Tavily search (wire domains) + published_date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"TmYTrWu-46yhNBAYzYsXxXtGAZ2Mg-Lw73_C9js7SdQeZph7s5Uk8231fPzA1Vfcv_58LXXQy7n9CJ5hTWD7Dw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/GUD","date":"2026-04-30","event_type":"financial_statement","title":"Notice of Knight Therapeutics' First Quarter 2026 Results","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/04/30/3284727/0/en/Notice-of-Knight-Therapeutics-First-Quarter-2026-Results-Conference-Call.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"uVoQUWJl3J9TxQYaX30Y-I3HqkU5Khh9SdTeJFCIFfTuE3gtRGqV1ZsBzGDBFnAu8ki9PuxI0sQ5RrsZJDJPAQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/GUD","date":"2026-03-27","event_type":"newswire_release","title":"Knight Therapeutics Inc. ranks on The Globe and Mail’s","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/fr/news-release/2026/03/27/3263967/0/en/Knight-Therapeutics-Inc-ranks-on-The-Globe-and-Mail-s-second-annual-Canada-s-Top-Growing-Women-Led-Companies-and-seventh-annual-Women-Lead-Here-benchmark-of-executive-gender-divers.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"2sJd9YUrtW-wNHu-kdnBOQ1SNxfWYoBXQ3Hz1bgbNhdcVLwtxnXGnAzWeFjNu17oH0gypemgLxddwCip9UybAw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/GUD","date":"2026-03-27","event_type":"newswire_release","title":"Knight Therapeutics Inc. ranks on The Globe and Mail’s","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/de/news-release/2026/03/27/3263967/0/en/Knight-Therapeutics-Inc-ranks-on-The-Globe-and-Mail-s-second-annual-Canada-s-Top-Growing-Women-Led-Companies-and-seventh-annual-Women-Lead-Here-benchmark-of-executive-gender-divers.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"G_y-iOTYR4TDfmow4QTTtRdRBs_PEY8HGp8-h9VEg9Op1hsYuonzYdBWs3A12FSsBiN4yfcd2jkF3LfTElThBw","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/GUD","date":"2026-03-12","event_type":"newswire_release","title":"Notice of Knight Therapeutics' Fourth Quarter and Year End","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2026/03/12/3254510/0/en/Notice-of-Knight-Therapeutics-Fourth-Quarter-and-Year-End-2025-Results-Conference-Call.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"zVnbahUlAZMMYUy9cnEyjEKalzRZgt7-YVfoRt8PB9gHpiDpRgyifT1YzM96fCWe8p6MQIFBOXQH-6dV6XsYBg","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}},{"cmr":"ca-cm-kg/TSX/GUD","date":"2025-09-26","event_type":"newswire_release","title":"Knight Therapeutics Inc. places No. 384 on The Globe and","wire":"GlobeNewswire","source":"GlobeNewswire","url":"https://www.globenewswire.com/news-release/2025/09/26/3157051/0/en/Knight-Therapeutics-Inc-places-No-384-on-The-Globe-and-Mail-s-seventh-annual-ranking-of-Canada-s-Top-Growing-Companies.html","read_by":"Tavily search (wire domains) + URL date","signature":{"alg":"EdDSA","kid":"allooloo-cmr-2026-10","protected":"eyJhbGciOiJFZERTQSIsImtpZCI6ImFsbG9vbG9vLWNtci0yMDI2LTEwIn0","signature":"mQ09ZjptY1vYs5OhBPOkdfA6NLASEqUpF843mMNAMrEl_UODYM1ztXQmN-yX9nsud0gwrEr_dJZCXytV9iuhCQ","jwks":"https://allooloo.ai/.well-known/jwks.json","over":"base64url(protected) + '.' + base64url(canonical JSON of the record without signature: keys sorted, compact)"}}],"events_signed":"allooloo-cmr-2026-10"}